These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
258 related items for PubMed ID: 19477207
1. Myxoma virus M130R is a novel virulence factor required for lethal myxomatosis in rabbits. Barrett JW, Werden SJ, Wang F, McKillop WM, Jimenez J, Villeneuve D, McFadden G, Dekaban GA. Virus Res; 2009 Sep; 144(1-2):258-65. PubMed ID: 19477207 [Abstract] [Full Text] [Related]
3. The myxoma virus M-T4 gene encodes a novel RDEL-containing protein that is retained within the endoplasmic reticulum and is important for the productive infection of lymphocytes. Barry M, Hnatiuk S, Mossman K, Lee SF, Boshkov L, McFadden G. Virology; 1997 Dec 22; 239(2):360-77. PubMed ID: 9434727 [Abstract] [Full Text] [Related]
7. Disruption of M-T5, a novel myxoma virus gene member of poxvirus host range superfamily, results in dramatic attenuation of myxomatosis in infected European rabbits. Mossman K, Lee SF, Barry M, Boshkov L, McFadden G. J Virol; 1996 Jul 22; 70(7):4394-410. PubMed ID: 8676463 [Abstract] [Full Text] [Related]
11. The poxviral scrapin MV-LAP requires a myxoma viral infection context to efficiently downregulate MHC-I molecules. Collin N, Guérin JL, Drexler I, Blanié S, Gelfi J, Boullier S, Foucras G, Sutter G, Messud-Petit F. Virology; 2005 Dec 20; 343(2):171-8. PubMed ID: 16185739 [Abstract] [Full Text] [Related]
12. Role of the myxoma virus soluble CC-chemokine inhibitor glycoprotein, M-T1, during myxoma virus pathogenesis. Lalani AS, Masters J, Graham K, Liu L, Lucas A, McFadden G. Virology; 1999 Apr 10; 256(2):233-45. PubMed ID: 10191189 [Abstract] [Full Text] [Related]
13. The complete DNA sequence of myxoma virus. Cameron C, Hota-Mitchell S, Chen L, Barrett J, Cao JX, Macaulay C, Willer D, Evans D, McFadden G. Virology; 1999 Nov 25; 264(2):298-318. PubMed ID: 10562494 [Abstract] [Full Text] [Related]
14. Construction and evaluation of live attenuated myxoma virus vaccines with targeted virulence gene deletions. Adams MM, van Leeuwen BH, Kerr PJ. Vaccine; 2008 Oct 29; 26(46):5843-54. PubMed ID: 18789367 [Abstract] [Full Text] [Related]
15. Coevolution of host and virus: the pathogenesis of virulent and attenuated strains of myxoma virus in resistant and susceptible European rabbits. Best SM, Kerr PJ. Virology; 2000 Feb 01; 267(1):36-48. PubMed ID: 10648181 [Abstract] [Full Text] [Related]
16. The α2,3-sialyltransferase encoded by myxoma virus is a virulence factor that contributes to immunosuppression. Boutard B, Vankerckhove S, Markine-Goriaynoff N, Sarlet M, Desmecht D, McFadden G, Vanderplasschen A, Gillet L. PLoS One; 2015 Feb 01; 10(2):e0118806. PubMed ID: 25705900 [Abstract] [Full Text] [Related]
18. Role of the C-terminal RDEL motif of the myxoma virus M-T4 protein in terms of apoptosis regulation and viral pathogenesis. Hnatiuk S, Barry M, Zeng W, Liu L, Lucas A, Percy D, McFadden G. Virology; 1999 Oct 25; 263(2):290-306. PubMed ID: 10544103 [Abstract] [Full Text] [Related]
19. Myxoma virus in the European rabbit: interactions between the virus and its susceptible host. Stanford MM, Werden SJ, McFadden G. Vet Res; 2007 Oct 25; 38(2):299-318. PubMed ID: 17296158 [Abstract] [Full Text] [Related]
20. Transforming growth factor alpha, Shope fibroma growth factor, and vaccinia growth factor can replace myxoma growth factor in the induction of myxomatosis in rabbits. Opgenorth A, Nation N, Graham K, McFadden G. Virology; 1993 Feb 25; 192(2):701-9. PubMed ID: 8380671 [Abstract] [Full Text] [Related] Page: [Next] [New Search]